References
- World Health Organization. (2001). Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. WHO Technical Report Series, Geneva, Switzerland.
- World Health Organization. (2002). WHO Traditional Medicine Strategy 2002–2005. WHO Technical Report Series, Geneva, Switzerland.
- Briggs D. The regulation of herbal medicines in Australia. Toxicology. 2002; 181–812: 565–70.
- Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW. Interactions of herbs with cytochrome P450. Drug Metab Rev. 2003; 35: 35–98.
- Yang X, Kulkarni AP. N-dealkylation of aminopyrine catalyzed by soybean lipoxygenase in the presence of hydrogen peroxide. J Biochem Mol Toxicol. 1998; 12: 175–83.
- Robert W, Flint J. Emotional arousal, blood glucose levels and memory modulation: three laboratory exercises in cognitive neuroscience. J Undergrad Neurosci Edu. 2004; 3: A16–23.
- Han C, Abas H, Sabariah I. Effect of Orthosiphon stamineus leaf extracts on hepatic cytochrome P450, UGT and GST activity in STZ-induced diabetic rats. JASA. 2009; 1: 1–8.
- Hussin A, Skett P. Lack of effect of insulin in hepatocytes isolated from streptozotocin-diabetic male rats. Biochem. Pharmacol. 1988; 37: 1683–6.
- Jagoda R, Josip R. Effects of vanadate on oleic acid induced insulin resistance in cultured rat hepatocytes. Diabetologia Croatica. 2004; 33: 17–21.
- Taher Y, Hussin A. In-vitro effect of a herbal product on aminopyrine metabolism in rat hepatocytes. Fitoterapia. 1998; LXIX: 265–68..
- Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J. 1953; 55: 416–21.
- Purwantiningsih, Abas HH, Kit L. Phase I drug metabolism study of the standardized extract of Eurycoma longifolia (TAF273) in rat hepatocytes. Int J Pharm Pharmac Sci. 2010; 2: 147–52..
- Oesch-Bartlomowicz B, Oesch F. Cytochrome-P450 phosphorylation as a functional switch. Arch Biochem Biophys. 2003; 409: 228–34.
- Oesch-Bartlomowicz B, Oesch F. Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme. Biochem Biophys Res Commun. 2005; 338: 446–49.
- Lin G, Cui Y, Liu X. Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat. Chem. Res. Toxicol. 2003; 16: 768–74.
- Skett P, Joels L. Different effects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rat. Biochem. Pharmacol. 1985; 34: 287–9.
- Xu M, Wang G, Xie H, Li H, Huang Q, Wang R, et al.. Gender difference regarding schizandrin pharmacokinetics in rats. Eur J Drug Metab Pharmacokinet. 2008; 33: 65–8.
- Han CJ, Abas HH. Effect of the Orthosiphon stamineus benth on aminopyrine metabolism in rat hepatocytes. Malaysian J Pharmaceutical Sciences. 2007; 5: 25–32.
- Koch KM, Palmer JL, Noordin N, Tomlinson JJ, Baidoo C. Sex and age differences in the pharmacokinetics of alosetron. Br J Clin Pharmacol. 2002; 53: 238–42.
- de Wildt SN, Trevor NJ, Imti C. The effect of age on drug metabolism. Paediatr Perinat Drug Ther. 2003; 5: 101–6.
- Khalid M. Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model. Exp Diabetes Res. 2009; 2009: 1–6.
- Cheng P, Morgan E. Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab. 2001; 2: 165–83.
- Schenkman J. Induction of diabetes and evaluation of diabetic state on P450 expression. Methods Enzymol. 1991; 206: 325–31.